Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP946139.RAgEBo3tS_elIdCa9E6rt-sMzRWmlL1_5AZlJ5aPaz2A0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP946139.RAgEBo3tS_elIdCa9E6rt-sMzRWmlL1_5AZlJ5aPaz2A0130_assertion type Assertion NP946139.RAgEBo3tS_elIdCa9E6rt-sMzRWmlL1_5AZlJ5aPaz2A0130_head.
- NP946139.RAgEBo3tS_elIdCa9E6rt-sMzRWmlL1_5AZlJ5aPaz2A0130_assertion description "[After exposure to such therapies, clones of MET-amplified cancer cells arise within the context of genetically heterogeneous tumors and-exploiting an ample platform of signaling pathways-drive recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946139.RAgEBo3tS_elIdCa9E6rt-sMzRWmlL1_5AZlJ5aPaz2A0130_provenance.
- NP946139.RAgEBo3tS_elIdCa9E6rt-sMzRWmlL1_5AZlJ5aPaz2A0130_assertion evidence source_evidence_literature NP946139.RAgEBo3tS_elIdCa9E6rt-sMzRWmlL1_5AZlJ5aPaz2A0130_provenance.
- NP946139.RAgEBo3tS_elIdCa9E6rt-sMzRWmlL1_5AZlJ5aPaz2A0130_assertion SIO_000772 25305631 NP946139.RAgEBo3tS_elIdCa9E6rt-sMzRWmlL1_5AZlJ5aPaz2A0130_provenance.
- NP946139.RAgEBo3tS_elIdCa9E6rt-sMzRWmlL1_5AZlJ5aPaz2A0130_assertion wasDerivedFrom befree-20150227 NP946139.RAgEBo3tS_elIdCa9E6rt-sMzRWmlL1_5AZlJ5aPaz2A0130_provenance.
- NP946139.RAgEBo3tS_elIdCa9E6rt-sMzRWmlL1_5AZlJ5aPaz2A0130_assertion wasGeneratedBy ECO_0000203 NP946139.RAgEBo3tS_elIdCa9E6rt-sMzRWmlL1_5AZlJ5aPaz2A0130_provenance.